Chicago Partners Investment Group LLC Rhythm Pharmaceuticals, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q4 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 3,696 shares of RYTM stock, worth $185,021. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,696
Previous 4,725
21.78%
Holding current value
$185,021
Previous $247,000
16.6%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RYTM
# of Institutions
216Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$338 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$329 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$305 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$305 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$184 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.79B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...